Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 5/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.45 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29517121 | 1.00 | ALDH1A1 (0.63) | ALDH1A1TDP1ALOX15USP2TSHR | |
| Chaulmoogric Acid SCHEMBL560850 | 1.00 | ALDH1A1 (0.63) | ALDH1A1TDP1ALOX15USP2TSHR | |
| Chaulmoogric Acid SCHEMBL560848 | 1.00 | ALDH1A1 (0.63) | ALDH1A1TDP1ALOX15USP2TSHR | |
| Chaulmoogric Acid SCHEMBL560849 | 1.00 | ALDH1A1 (0.63) | ALDH1A1TDP1ALOX15USP2TSHR | |
| SCHEMBL2491883 | 1.00 | ALDH1A1 (0.63) | ALDH1A1TDP1ALOX15USP2TSHR | |
| SCHEMBL580439 | 1.00 | ALDH1A1 (0.63) | ALDH1A1TDP1ALOX15USP2TSHR | |
| SCHEMBL4558351 | 1.00 | ALDH1A1 (0.63) | ALDH1A1TDP1ALOX15USP2TSHR | |
| SCHEMBL2494531 | 1.00 | ALDH1A1 (0.63) | ALDH1A1TDP1ALOX15USP2TSHR | |
| SCHEMBL17540730 | 0.98 | ALDH1A1 (0.60) | ALDH1A1TDP1ALOX15USP2TSHR | |
| Chaulmoogric Acid SCHEMBL15865192 | 0.95 | ALDH1A1 (0.62) | ALDH1A1TDP1ALOX15USP2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 530 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116660397-A | Quality detection method of musk or musk extract for treating acute ischemic stroke | 成都中医药大学 | 2023-08-29 | — | — | CN | claimed |
| CN-111110686-A | Application of fructose diphosphate in preparing medicine for treating affective disorder | 四川大学华西医院 | 2020-05-08 | — | — | CN | claimed |
| US-9931289-B2 | Cosmetic or pharmaceutical formulation | FORWARD SCOUT ENTERPRISES PTY LTD (AU) | 2018-04-03 | — | — | US | claimed |
| US-20150328323-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | SATYAM APPARAO (IN) | 2015-11-19 | — | — | US | claimed |
| CN-102482424-B | Silicone-modified fatty acids, method for the production and use thereof | MOMENTIVE PERFORMANCE MAT INC | 2015-06-10 | — | — | CN | claimed |
| US-8993117-B2 | Devices with multiple surface functionality | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2015-03-31 | — | — | US | claimed |
| US-8846843-B2 | Silicone modified fatty acids, method of preparation and usage thereof | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2014-09-30 | — | — | US | claimed |
| WO-2014111957-A1 | NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS | SATYAM APPARAO (IN) | 2014-07-24 | — | — | WO | claimed |
| EP-2473550-B1 | SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF | MOMENTIVE PERFORMANCE MAT INC (US) | 2014-05-07 | — | — | EP | claimed |
| US-20140037772-A1 | Cosmetic or Pharmaceutical Formulation | FORWARD SCOUT ENTERPRISES PTY LTD (AU) | 2014-02-06 | — | — | US | claimed |
| WO-2012116391-A1 | COSMETIC OR PHARMACEUTICAL FORMULATION | LIEN WENDY (AU) | 2012-09-07 | — | — | WO | claimed |
| EP-2473550-A1 | SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF | Momentive Performance Materials Inc. (US) | 2012-07-11 | — | — | EP | claimed |
| CN-102482424-A | Silicone-modified fatty acids, method for the production and use thereof | MOMENTIVE PERFORMANCE MAT INC | 2012-05-30 | — | — | CN | claimed |
| US-20120121661-A1 | DEVICES WITH MULTIPLE SURFACE FUNCTIONALITY | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2012-05-17 | — | — | US | claimed |
| WO-2011132171-A1 | NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS | PIRAMAL LIFE SCIENCES LIMITED (IN) | 2011-10-27 | — | — | WO | claimed |
| US-20110263526-A1 | Nitric Oxide Releasing Prodrugs of Therapeutic Agents | PIRAMAL LIFE SCIENCES LIMITED (IN) | 2011-10-27 | — | — | US | claimed |
| WO-2011080722-A2 | USE OF SKIN PERMEATION AND RETENTION ENHANCER COMPOUND IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS AND COSMETIC AND PHARMACEUTICAL PRODUCTS CONTAINING SAID COMPOUND | NATURA COSMETICOS S.A (BR) | 2011-07-07 | — | — | WO | claimed |
| WO-2011028214-A1 | SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2011-03-10 | — | — | WO | claimed |
| US-20100040570-A1 | SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2010-02-18 | — | — | US | claimed |
| WO-2000022909-A2 | SYSTEMS FOR ORAL DELIVERY | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 2000-04-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140037772-A1 | Cosmetic or Pharmaceutical Formulation | HM13, MMP13, CD44 | ALDH1A1 2825/4885TDP1 3542/4885ALOX15 171/4885 |
| US-20100040570-A1 | SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF | FASN, ELOVL5, SCD5 | ALDH1A1 1282/4885TDP1 4749/4885ALOX15 35/4885 |
| US-20110263526-A1 | Nitric Oxide Releasing Prodrugs of Therapeutic Agents | NOS2, NOS1, NOS3 | ALDH1A1 204/4885TDP1 1017/4885ALOX15 233/4885 |
| US-20120121661-A1 | DEVICES WITH MULTIPLE SURFACE FUNCTIONALITY | PHOSPHO1, CD44, SELP | ALDH1A1 2513/4885TDP1 1536/4885ALOX15 2852/4885 |
| US-20150328323-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | NOS2, NOS1, PTGIS | ALDH1A1 291/4885TDP1 794/4885ALOX15 230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.